miércoles, 1 de junio de 2016

Fogarty International Center

Fogarty International Center

Funding news for global health researchers and partners from Fogarty at NIH

A medical worker checks the bloodpressure of a patient in a clinic

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration.
NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.
  • Silencing of HIV-1 Proviruses (R61/R33) (RFA-AI-16-038)
    Application Receipt Date(s): December 7, 2016
  • Integrative Research on Polysubstance Abuse and Addiction (R21/R33) (PAR-16-291)
    Application Receipt/Submission Date(s): Standard dates apply
  • Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21) (PAR-16-278)
    Application Receipt/Submission Date(s): Standard dates apply
  • Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R01) (PAR-16-276) and (R21) (PAR-16-277) 
    Application Receipt/Submission Date(s): October 13, 2016; and more
  • Factors Underlying Differences in Female and Male for Dental, Oral, and Craniofacial Diseases and Conditions (R01) (PA-16-295) and (R21) (PA-16-296) 
    Application Receipt/Submission Date(s): Standard dates apply
  • Request of Proposal (RFP) Announcement: Pre-Clinical Models of Infectious Diseases, NIAID-DMID-NIHAI2016059 (NOT-AI-16-058)
  • Patient-Centered Outcomes Research from AHRQ
    Application Receipt/Submission Date(s): Standard dates apply
    Note: Foreign institutions may participate in projects as members of consortia or as subcontractors.
    • Developing New Clinical Decision Support to Disseminate and Implement Patient-Centered Outcomes Research Findings (R18) (PA-16-282)
    • Scaling Established Clinical Decision Support to Facilitate the Dissemination and Implementation of Patient-Centered Outcomes Research Findings (R18) (PA-16-283)
  • NIH Administrative Supplements:
    • Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Admin Supp) (PA-16-287) 
      Application Receipt/Submission Date(s): Multiple dates, see announcement.
    • Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) (PA-16-288)
      Application Receipt/Submission Date(s): Due dates may vary by awarding IC
    • Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp) (PA-16-289)
    • More about Administrative Supplements from the NIH Office of Extramural Research
Information related to opportunities from other organizations focusing on global health and foreign collaboration.
  • The U.K. Medical Research Council (MRC) Global Challenges Research Fund seeks applications for its Foundation Awards to address global challenges in health, infection and food security. Applications need to be submitted by an eligible UK research organization, with a UK principal investigator. Researchers from LMIC higher education institutions and non-profit research institutions are welcomed as co-investigators.
    Application deadline: June 22, 2016

Funding News

NIH funding news that may be relevant to global health researchers.
  • NIH Parent Announcements for Post-award Administrative Action:
  • Request for Information (RFI): Guidance for Opportunities in Neuroethics (NIH BRAIN Initiative) (NOT-MH-16-014)
  • Request for Information (RFI): Characterizing and Understanding the Organization of Individual Cells within Human Tissues (NOT-RM-16-025)
  • Notice of Change to Key Dates in PAR-16-254 Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01) (NOT-AI-16-054)
  • Notice of National Heart, Lung, and Blood Institute (NHLBI) Participation in PA-16-183 Limited Competition: Rare Diseases Clinical Research Network (RDCRN) Project Supplements for Clinical Trials to Repurpose Drugs in Collaboration with E-Rare Awardees (NOT-HL-16-322)

Upcoming Deadlines

No hay comentarios:

Publicar un comentario